Orbital Atherectomy Treatment Of Severely Calcified Coronary Lesions: Final 3-year Results Of The ORBIT II Trial - Jeffrey Chambers, MD, FSCAI

↳ This is a section part of Moment: CRT 2016 Coronary - New Strategies for the Treatment of Calcified Lesions

Add this Moment to your Passport

Learn from this moment and keep it forever.

add to passport

$12.99

This moment is included in Simple Premium - Get started for free.

FREE with Simple Premium

Start your 30-day free trial

Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Orbital Atherectomy Treatment Of Severely Calcified Coronary Lesions: Final 3-year Results Of The ORBIT II Trial presented by Jeffrey Chambers, MD, FSCAI at CRT 2016

Add this Moment to your Passport

Learn from this moment and keep it forever.

add to passport

$12.99

This moment is included in Simple Premium - Get started for free.

FREE with Simple Premium

Start your 30-day free trial

Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

Interventional Cardiologists
Interventional Fellows

Supported by an educational grant from Cardiovascular Systems, Inc.

Session Name: Protected PCI: New Strategies for the Treatment of Calcified Lesions (Supported by an educational grant from Cardiovascular Systems, Inc.)
Track: Coronary

Learning Objectives

Update in advances in treatment strategy of Calcified Lesions

Other Components in this Moment

Overview

Calcium in the Peripheral and Coronary Arteries: The Pathologist View - Renu Virmani, MD

Updated Evidence for Treatment of Calcified Lesions: What Are the Options? - Philippe Genereux, MD

Interesting Cases from ORBIT Trials - Jeffrey Chambers, MD, FSCAI

My Best and Worst Cases of Orbital Atherectomy: Learning to Use a New Tool - Itsik Ben-Dor, MD

Vessel Preparation of Calcified Lesions: Why is it Necessary - Augusto Pichard, MD, FSCAI

Orbital Atherectomy Treatment Of Severely Calcified Coronary Lesions: Final 3-year Results Of The ORBIT II Trial - Jeffrey Chambers, MD, FSCAI